APOC3 and fatty liver disease: 316 Prohaska Prohaska TA TA Alexander Alexander VJ VJ Karwatowska-Prokopczuk Karwatowska-Prokopczuk E E Tami Tami J J Xia Xia S S Witztum Witztum JL JL APOC3 Inhibition with Volanesorsen Reduces Hepatic Steatosis in Patients with Severe Hypertriglyceridemia APOC3 Inhibition with Volanesorsen Reduces Hepatic Steatosis in Patients with Severe Hypertriglyceridemia J Clin Lipidol J Clin Lipidol 2023 2023 17 17 3 3 406 406 411 411 10.1016/j.jacl.2023.04.007 10.1016/j.jacl.2023.04.007 37164837 37164837